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Alternative Splicing in CaV2.2 RegulatesNeuronal Trafficking
via Adaptor Protein Complex-1Adaptor ProteinMotifs
NatsukoMacabuag and Annette C. Dolphin
Department of Neuroscience, Physiology and Pharmacology, University College London, LondonWC1E 6BT, United Kingdom
N-typevoltage-gated calcium(CaV2.2) channels are expressed inneurons and targeted to theplasmamembraneofpresynaptic terminals,
facilitating neurotransmitter release. Here, we find that the adaptor protein complex-1 (AP-1) mediates trafficking of CaV2.2 from the
trans-Golgi network to the cell surface. Examination of splice variants of CaV2.2, containing either exon 37a (selectively expressed in
nociceptors) or 37b in the proximal C terminus, reveal that canonical AP-1 bindingmotifs, Yxx and [DE]xxxL[LI], present only in exon
37a, enhance intracellular trafficking of exon 37a-containing CaV2.2 to the axons and plasmamembrane of rat DRG neurons. Finally, we
identify differential effects of dopamine-2 receptor (D2R) and its agonist-induced activation on trafficking of CaV2.2 isoforms. D2R
slowed the endocytosis of CaV2.2 containing exon 37b, but not exon 37a, and activation by the agonist quinpirole reversed the effect of the
D2R. Our work thus reveals key mechanisms involved in the trafficking of N-type calcium channels.
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Introduction
N-type voltage gated calcium channels (CaV2.2) are expressed
predominantly in central and peripheral neurons (Nowycky et
al., 1985; Dubel et al., 1992; Westenbroek et al., 1998). At presyn-
aptic terminals, CaV2.2 channels are recruited to the active zone
where they are activated upon the arrival of action potentials,
triggering influx of Ca 2 through the pore-forming 1 subunit
and causing neurotransmitter release (Reynolds et al., 1986;
Hirning et al., 1988; Hibino et al., 2002; Maximov and Bezproz-
vanny, 2002; Han et al., 2011; Kaeser et al., 2011). Neurons are
morphologically complex cells that are highly polarized for their
specialized functions, and several studies have elucidated how
CaV2.2 channels are targeted to the plasma membrane where they
are required. The association of CaV2 channels with auxiliary
subunits,  and 2, is thought to be important not only for the
biophysical properties, but also for correct intracellular traffick-
ing of the channels (De Waard et al., 1994; Gurnett et al., 1996;
Dolphin, 2012; Cassidy et al., 2014). Furthermore, interaction of
CaV2.2 with G-protein-coupled receptors (GPCRs) is also re-
ported to influence the cell surface expression of CaV2.2 (Altier et
al., 2006; Kisilevsky and Zamponi, 2008; Kisilevsky et al., 2008;
Evans et al., 2010). However, the precise mechanisms of CaV2.2
trafficking between intracellular organelles and the plasma mem-
brane are poorly understood.
Posttranscriptional modification such as alternative splicing
provides CaV2.2 with further functional variation, which fine-
tunes neuronal excitability. To elucidate how CaV2.2 channels are
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Significance Statement
CaV2.2 channels are important for neurotransmitter release, but how they are trafficked is still poorly understood. Here, we
describe a novel mechanism for trafficking of CaV2.2 from the trans-Golgi network to the cell surface which is mediated by the
adaptor protein AP-1. Alternative splicing of exon 37 produces CaV2.2-exon 37a, selectively expressed in nociceptors, or CaV2.2-
exon 37b, which is the major splice isoform. Our study reveals that canonical AP-1 binding motifs (Yxx and [DE]xxxL[LI]),
present in exon 37a, but not 37b, enhance intracellular trafficking of exon 37a-containing CaV2.2 to axons and plasmamembrane
of DRG neurons. Interaction of APs with CaV2.2 channels may also be key underlying mechanisms for differential effects of the
dopamine D2 receptor on trafficking of CaV2.2 splice variants.
14636 • The Journal of Neuroscience, October 28, 2015 • 35(43):14636–14652
trafficked to the plasma membrane in neurons, we investigated
whether there are differences in trafficking between two CaV2.2
alternative splice variants of exon 37 in the proximal C terminus
of CaV2.2, which is alternatively spliced in a mutually exclusive
manner to give rise to CaV2.2 channels that contain either exon
37a (e37a) or exon 37b (e37b; Fig. 1A; Lipscombe et al., 2002; Bell
et al., 2004). This introduces a relatively restricted change in the
amino acid sequence, but nevertheless, CaV2.2e37a has a larger
whole-cell current compared to CaV2.2e37b (Bell et al., 2004;
Castiglioni et al., 2006; Raingo et al., 2007; Marangoudakis et al.,
2012). Expression of exon 37a-containing CaV2.2 channels is en-
riched in small dorsal root ganglion (DRG) neurons, including
nociceptors (Bell et al., 2004; Castiglioni et al., 2006; Altier et al.,
2007). We noted that the exon 37a sequence introduces two ca-
nonical adaptor protein (AP) motifs that are absent from exon
37b. Together with several lines of evidence that the C terminus of
CaV channels is important in channel targeting (Bourinet et al.,
1999; Gao et al., 2000; Kepplinger et al., 2000; Krovetz et al., 2000;
Hall et al., 2013), we hypothesized that CaV2.2 channels contain-
ing e37a may be more readily trafficked to the plasma membrane
compared to CaV2.2e37b channels by virtue of these motifs.
To demonstrate whether alternative splicing regulates trafficking
of CaV2.2, we took advantage of our recently developed functional
exofacially tagged CaV2.2 channels (Cassidy et al., 2014) to visualize
their cellular localization in both Neuro2a (N2a) cells and DRG neu-
rons. We used electrophysiological, immunocytochemical, and live-
cell labeling approaches to demonstrate that CaV2.2 channels
containing e37a are trafficked more readily than those with e37b to
the plasma membrane and to the processes of DRG neurons, as a
result of enhanced forward trafficking from the Golgi apparatus to
the plasma membrane. We also reveal that this trafficking pathway is
indeed dependent on specific motifs in e37a that mediate interaction
with AP-1, which is involved in clathrin-mediated protein sorting
(Bonifacino and Traub, 2003). Furthermore, we also present evi-
dence that the dopamine-2 receptor (D2R) has a stabilizing effect on
CaV2.2e37b channels, leading to increased cell surface expression, but
notonCaV2.2e37achannels,andthiseffectonendocytosisisreversedby
D2R activation. Our data suggest that D2R activation-mediated inter-
nalization of CaV2.2 involves interaction between AP-2 and the AP
binding motifs in the proximal C terminus of CaV2.2. Together, we
provideevidenceforinvolvementoftheAP-familyinCaV2.2trafficking,
which is modulated by alternative splicing.
Materials andMethods
Constructs. The following cDNA plasmids were used: CaV2.2 (D14157),1b
(X61396, from T. P. Snutch, University of British Columbia, Vancouver,
Canada), 2-1 (M86621), and D2R (NM_012547). All the cDNAs were
subcloned into pMT2 expression vectors for tsA-201 transfection, and into
pcDNA3.0 or pRK5 expression vectors for N2a and DRG transfection. Hem-
agglutinin (HA)- and bungarotoxin-binding site (BBS)-tagged CaV2.2 were
generated as described previously (Cassidy et al., 2014). Green fluorescent
protein (GFP)-HA-tagged CaV2.2 was generated by subcloning HA-CaV2.2
into the N terminus of GFP-CaV2.2 (Raghib et al., 2001) by restriction digest.
CaV2.2e37a AP binding motif mutants were generated using the primers
shown in Table 1 at the following locations: Y1775A (Y/A), L1777A (L/A),
L1777A/L1778A (LL/AA), and Y1775A/L1777A/L1778A (YSLL/ASAA).
AP-1a shRNA with mCerulean in pSUPER vector was a gift from M. A.
Cousin (University of Edinburgh, Edinburgh, UK) (Cheung and Cousin,
2012). The scrambled AP-1 shRNA was generated from the primers contain-
ing BglII and HindIII sites (Table 1). The PCR product was subcloned into
pSUPER expression vector. AP-1 1A WT and V98S in pcDNA3.1 vectors
were gifts from J. S. Bonifacino (NIH, Bethesda, MD) (Jain et al., 2015). AP-2
2 WT and F176A/D178S in pcDNA3.1 vectors were gifts from M. S. Rob-
inson (Cambridge University, Cambridge, UK) (Motley et al., 2006). All
constructs were verified by DNA sequencing.
Cell culture and transfection. tsA-201 cells were cultured in DMEM sup-
plemented with 10% fetal bovine serum (FBS), 1 unit/ml penicillin, 1g/ml
streptomycin, and 1% GlutaMAX (Invitrogen). tsA-201 cells were trans-
fected using Fugene 6 (Promega) according to the manufacturer’s protocol.
Mouse neuroblastoma N2a cells were cultured in 50% DMEM and 50%
Opti-MEM supplemented with 5% FBS, 1 unit/ml penicillin, 1g/ml strep-
tomycin, and 1% GlutaMAX. N2a cells were transfected using PolyJet (Sig-
naGen Laboratories) according to the manufacturer’s protocol. Transfected
cells were plated onto coverslips or glass-bottomed dishes (MatTek) coated
with poly-L-lysine and cultured in a 5% CO2 incubator at 37°C. Postnatal day
10 DRG neurons were isolated from male Sprague Dawley rats and trans-
fected with Amaxa Nucleofector (Lonza) according to the manufacturer’s
protocol. Transfected neurons were plated on the coverslips coated with
poly-L-lysine and cultured in DMEM/F-12 supplemented with 10% FBS, 1
units/ml penicillin, 1 g/ml streptomycin, 1% GlutaMAX, and 100 ng/ml
NGF in a 5% CO2 incubator at 37°C. Pertussis toxin (PTX) treatment in-
volved 16 h incubation with 500 ng/ml PTX before the experiment.
Western blotting. After 40–48 h expression, cells were harvested in PBS
containing Complete Protease Inhibitor Cocktail (PI; Roche; 1 tablet/50 ml).
The cells were lysed in cell lysis buffer [50 mM Tris, pH 7.4, 50 mM NaCl,
PI, 1% IGEPAL CA-630 (octylphenoxypolyethoxyethanol), 25 mM
N-ethylmaleimide] by sonication and were then left on ice for 45 min. The
cell lysate was clarified by centrifugation at 14,000 g for 20 min. Protein
samples were denatured by heating at 55°C for 15 min with reducing Laem-
mli sample buffer (2% SDS, 2% glycerol, 0.02% bromophenol blue, 50 mM
Tris HCl, pH 6.8, 20 mM DTT). Proteins were separated on a 3–8% Tris-
acetate gel (Invitrogen) and transferred onto a polyvinylidene fluoride mem-
brane. The membrane was blocked in Tris-buffered saline solution (10 mM
Tris, pH7.4, 500 mM NaCl, 0.5% IGEPAL CA-630) with 3% BSA and was
then incubated with the primary antibody (1:1000) overnight at 4°C. The
secondary antibody conjugated with horseradish peroxide (HRP; 1:3000)
was incubated with the membrane at room temperature for 1 h. The proteins
were detected using ECL Plus Western blotting detection reagents (GE
Healthcare) according to the manufacturer’s protocol and scanned using the
fluorescent detection mode on a Typhoon 9410 (GE Healthcare). Primary
antibodies used were rabbit anti-CaV2.2 II–III loop (Raghib et al., 2001) and
mouse anti-GAPDH. Secondary antibodies used were goat anti-rabbit-HRP
and goat anti-mouse-HRP (Invitrogen).
Immunocytochemistry. After 40 –72 h expression, cells were fixed with
4% paraformaldehyde (PFA) in PBS, pH7.4, at room temperature for 10
min. For labeling the HA epitope on the cell surface in nonpermeabilized
conditions, the cells were incubated with primary antibody with 2.5%
BSA and 10% goat serum in PBS at room temperature for 1 h for N2a
cells, or overnight at 4°C for DRG neurons. The secondary antibody was
added with 2.5% BSA and 10% goat serum in PBS and incubated for 1 h
at room temperature. In experiments in which the D2R was activated,
100 nM quinpirole (Quin; Sigma-Aldrich) was added to N2a cells in
Krebs–Ringer solution with HEPES [KRH; containing (in mM) 125 NaCl,
5 KCl, 1.1 MgCl2, 1.2 KH2PO4, 2 CaCl2, 6 glucose, 25 HEPES, and 1
NaHCO3] at 37°C for 30 min. PTX (500 ng/ml; Invitrogen) was added to
the cells in the culture media overnight. To label intracellular proteins,
the cells were permeabilized with 0.2% Triton X-100 in PBS for 10 min.
The primary and secondary antibodies in 2.5% BSA and 10% goat serum
were added to the cells as above. Cell nuclei were stained with 0.5 M
DAPI (4,6-diamidino-2-phenylindole) in PBS for 10 min. The cover-
slips were mounted onto glass slides using Vectashield mounting medium
(Vector Laboratories). Primary antibodies used were rabbit anti-CaV2.2
(Raghib et al., 2001), rat anti-HA (Roche; 1:500) or mouse anti-Myc 9E10
(Santa Cruz Biotechnology; 1:100). Secondary antibodies (1:500) used were
Alexa Fluor 594 anti-rabbit, Alexa Fluor 594 anti-rat, Alexa Fluor 647 anti-
mouse (Invitrogen), or FITC anti-rat (Sigma-Aldrich).
Endocytosis and forward trafficking assay.After 40 h expression, N2a cells
in glass-bottomed dishes were washed twice with KRH. For the endocytosis
assay, cells were incubated with 10 g/ml -bungarotoxin Alexa Fluor 488
conjugate (BTX488; Invitrogen) at 17°C for 30 min. The unbound BTX488
was removed by washing with KRH, and the labeled cells were returned to
37°C for the kinetic assay. Endocytosis was stopped by fixing the cells with
cold 4% PFA in PBS at the specified time. For endocytosis experiments in
which the D2R was activated, 100 nM Quin was added to the cells in KRH
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Figure1. Alternative splicing in CaV2.2 exon 37 and electrophysiological properties of CaV2.2e37a and e37b.A, Mutually exclusive alternative splicing in CaV2.2 exon 37 and an alignment of exon
37a and 37b amino acid sequences.B, Representativewhole-cell current recordings (left) andmean current–voltage relationship (right) for CaV2.2e37a and CaV2.2e37b in tsA-201 cellswith2-1
and1b [peak current density (pA/pF), e37a (red),245.0 29.1 (5mV, n 22); e37b (blue),156.0 17.7 (10mV, n 24)]. C, The Gmax of e37a was significantly larger than that of
e37b ( p0.0189).D,V50,act of e37awas significantly hyperpolarized comparedwith e37b ( p0.0009).E, D2 receptor-mediated inhibitionof CaV2.2e37 isoforms.Whole-cell currentwas recorded
before and after 300 nM quinpirole treatment. The voltage-clamp protocol is shown on the top. The exemplary current traces of CaV2.2e37b (black, control; blue, 300 nMQuin) and CaV2.2e37a (gray,
control; red, 300nMQuin) are also shown. The relative current expressed as P2/P1was significantly smaller for CaV2.2e37a (n 19) compared to CaV2.2e37b (n 22) in the presence of 300nMQuin
( p 0.0101), showing that the inhibition of CaV2.2e37a is more voltage-independent. n, Number of cells. *p	 0.05; ***p	 0.001 (Student’s unpaired t test).
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buffer after the BTX488 labeling stage. For the forward trafficking assay, the
cells were incubated with 10g/ml unlabeled -bungarotoxin (BTX; Invit-
rogen) at 17°C for 30 min. The unbound BTX was washed off with KRH, and
the cells were then incubated with 10g/ml BTX488 in KRH at 37°C. To stop
the reaction, cells were washed twice with cold KRH and then fixed with 4%
PFA in PBS at specified times for the kinetic assay. Brefeldin A [BFA; 200
ng/ml (0.71 M); Sigma-Aldrich] in 0.4% DMSO was added to the cells in
FBS-free N2a cell culture medium for 4 h before the experiment, and during
the experiment in KRH buffer. The cells were then permeabilized, and intra-
cellular CaV2.2 and nuclei were labeled as described above. The 13 mm
coverslips were mounted onto dishes using Vectashield mounting medium.
Confocal microscopy and image analysis. All images were acquired using
an LSM 780 Meta scanning confocal microscope (Zeiss) equipped with a
Plan-Apochromat 63/1.4 numerical aperture (NA) or 40/1.3 NA differ-
ential interference contrast (DIC)II oil-immersion objective lens in 16-bit
mode (Cassidy et al., 2014). The laser powers, gains, and acquisition settings
were kept constant for images that were used subsequently for quantifica-
tion. For cell surface expression analysis, images were taken with 0.7 m
optical sections. For neurite expression analysis, images were taken with 0.9
m optical sections inZ-stack and presented as maximum projections. Con-
focal images were imported and analyzed in ImageJ (NIH). The membrane
fluorescence was quantified using the freehand brush tool with a selection
width of 0.66m and tracing the membrane region manually to acquire the
fluorescence density, which is independent of cell circumference. Neurite
fluorescence intensity was quantified using the freehand brush tool with a
selection with of 2 m and manually tracing the entire neurites using
mCherry expression as a marker. Intracellular and whole-cell fluorescence
densities were quantified using freehand selection, omitting the
signal intensity from the nuclei. The background fluorescence density in
each channel was also taken from the same image and subtracted from the
signal density. For the endocytosis and forward trafficking assays, the nor-
malized membrane fluorescent intensities were fitted to a single exponential.
The forward trafficking rates were derived from the reciprocal of the time
constant () of the single exponential (1/).
Electrophysiology. After 40 h expression, cells were replated in cell cul-
ture medium at a 1 in 3 or 5 dilution, depending on their confluency.
Transfected cells were identified by coexpression of CD8, which was
detected with CD8 Dynabeads (Invitrogen). Whole-cell currents were
recorded in voltage-clamp mode in following solutions: intracellular
(electrode) solution (in mM), 140 Cs-aspartate, 5 EGTA, 2 MgCl2, 0.1
CaCl2, 2 K2ATP, 20 HEPES, pH 7.2, 310 mOsm; extracellular solution (in
mM), 1 BaCl2, 3 KCl, 1 NaHCO3, 1 MgCl2, 10 HEPES, 4 D-glucose, 160
tetraethylammonium bromide, pH 7.4, 320 mOsm. The borosilicate
glass electrode resistance was between 1.5 and 4 M
. Cell capacitance
and series resistance were compensated to 80%. Whole-cell currents
were recorded with an Axopatch-200B amplifier using pClamp 9 or 10
(Molecular Devices). The cells were held at90 mV, and 50 ms pulses
were applied in 5 mV steps between 30 and 70 mV. For D2R
activation, Quin was applied by local application through a perfusion
system. To correct for the leak current, a P/8 leak subtraction protocol
was applied. Recordings were filtered at 5 kHz (low-pass four-pole
Bessel filter) in the amplifier. The digital low-pass eight-pole Bessel
filter with a 1 kHz, 3 dB cutoff was applied in Clampfit 10.9 (Molec-
ular Devices) before the current amplitudes were determined. Aver-
age peak currents were taken between 8 and 13 ms after the test
potentials were applied and normalized to the cell capacitance to
obtain the current density. Current–voltage ( I–V) relationships were
fitted to the following modified Boltzmann equation to give V50 acti-
vation (V50,act), conductance (Gmax), and reversal potential (Vrev)
using Origin 7: I  Gmax(V  Vrev)/1  e
(VV50,act )/k.
Statistical analysis. Immunocytochemistry and trafficking experi-
ments with N2a cells were repeated with n 3–5 transfections, and30
to 50 cells were analyzed for each experiment. All data were presented as
pooled in the result graphs except for the trafficking rates and time con-
stants, which are averages of separate experiments. Statistical analysis was
performed using either Student’s unpaired t test or one-way ANOVA
with Bonferroni’s post hoc test as appropriate in GraphPad Prism. All the
data are expressed as mean SEM.
Results
Exofacially tagged CaV2.2 channels containing e37a conduct a
larger whole-cell current than those containing e37b
To compare the localization of CaV2.2 isoforms containing e37a
or e37b (Fig. 1A), both channels were exofacially tagged with HA
or BBS tags as described previously (Cassidy et al., 2014). First, to
demonstrate that the exofacial tag does not affect the function of
the CaV2.2 splice variant channels, whole-cell Ba
2 currents were
recorded from tsA-201 cells transiently expressing HA-tagged
CaV2.2e37a and CaV2.2e37b, together with the auxiliary subunits
2-1 and 1b. The average whole-cell current density of
CaV2.2e37a was significantly larger than that of CaV2.2e37b at
test potentials between25 and 15 mV (Fig. 1B), and the average
whole-cell conductance (Gmax) for CaV2.2e37a currents was
1.5-fold greater than that for Cav2.2e37b currents (Fig. 1C).
Furthermore, Cav2.2e37a channels were activated at a more hy-
perpolarized potential than those containing e37b (Fig. 1D).
These properties of CaV2.2e37a and e37b currents are in agree-
ment with the previous reports in expression systems (Bell et al.,
2004; Castiglioni et al., 2006; Raingo et al., 2007) and in trans-
genic mice (Andrade et al., 2010).
Moreover, these tagged CaV2.2 isoforms also exhibited differ-
ential voltage-dependence upon G-protein-coupled receptor
(GPCR) activation, in a similar manner to that reported previ-
ously (Raingo et al., 2007; Andrade et al., 2010). Using a double
pulse protocol, in the presence of the D2R, CaV2.2e37a and
CaV2.2e37b currents [in the first test pulse (P1)] were inhibited
by a D2R-specific agonist, quinpirole. When a large depolarizing
pulse was applied just before the second test pulse (P2) in the
presence of Quin, Cav2.2e37a exhibited significantly smaller rel-
ative currents (P2/P1), compared to CaV2.2e37b (Fig. 1E). This
voltage-independent inhibition of CaV2.2e37a by D2R activation
largely agrees with previous findings with GABAB and -opioid
receptor activation in expression systems and in transgenic mice
(Raingo et al., 2007; Andrade et al., 2010). These results demon-
strate that the CaV2.2e37 isoforms containing exofacial tags func-
tion as predicted by previous studies.
CaV2.2e37a channels are preferentially expressed at the
cell membrane
To investigate whether the increased current exhibited by
CaV2.2e37a results from an effect on trafficking, mediating altered
cellular localization of the CaV2.2e37 isoforms, we added GFP to the
N terminus of the CaV2.2 splice variants containing the exofacial HA
Table 1. Primers used in generating CaV2.2e37a AP-bindingmutants and
scrambled AP-1 shRNA
Primers Sequence (5 to 3)
a1B-Kpn21-F CACAATAACTTCCGGACGTTTCTGCAG
LA-F GGATATGTACAGTGCGTTGCGTTGTATTGC
LA-R GCAATACAACGCAACGCACTGTACATATCC
LLAA-F GGATATGTACAGTGCGGCGCGTTGTATTGC
LLAA-R GCAATACAACGCGCCGCACTGTACATATCC
YA-F AGGATATGGCCAGTTTGTTGCGTTG
YA-R CAACGCAACAAACTGGCCATATCCT
YALLAA-F AGGATATGGCCAGTGCGGCGCGTTGTATTGC
YALLAA-R GCAATACAACGCGCCGCACTGGCCATATCCT
AP-1a_Scrambled-A
GATCCCCGAGACCTTAAGATCCTATTTTCAAG
AGAAATAGGATCTTAAGGTCTCTTTTTA
AP-1a_Scrambled-B
AGCTTAAAAAGAGACCTTAAGATCCTATTTCTCT
TGAAAATAGGATCTTAAGGTCTCGGG
The forward (F) and reverse (R) primers used in generating the constructs described in Materials and Methods are
shown here.
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tag (Fig. 2A). The advantage of these constructs is that expression of
the channel at the plasma membrane can be detected by immuno-
staining for the cell surface HA epitope in nonpermeabilizing con-
ditions after fixation and the total channel localization determined
by GFP simultaneously. These tagged CaV2.2 isoforms were tran-
siently expressed in neuronal cell line N2a in the presence of 2-1
and 1b (Fig. 2A). This revealed a larger plasma membrane expres-
sion level of Cav2.2e37a compared to Cav2.2e37b, without altering
the whole-cell expression level of the channels (Fig. 2B). GFP at the N
terminus did not alter this cellular localization pattern, as the same
observation was made from cells expressing the HA-tagged CaV2.2
isoforms, in which the intracellular channels were immunolabeled
with anti-CaV2.2 II–III loop antibody, after permeabilization (Fig.
2C). This confirmed that CaV2.2 channels containing e37a are pref-
erentially localized in the plasma membrane and that the increase in
the cell surface expression is not due to the overall increase in the
protein expression level.
Preferential expression of CaV2.2e37a at the cell membrane was
also exhibited in the cell bodies of isolated cultured DRG neurons
expressing the HA-tagged GFP-CaV2.2 isoforms (Fig. 3A,B). The
amount of tagged CaV2.2e37a channels in the neurites of these DRG
neurons was also significantly higher than for CaV2.2e37b, without
altering the level of an expression marker mCherry that was cotrans-
fected to visualize the entire field of neurites (Fig. 3C,D). CaV2.2e37a
channels were also expressed significantly further away from the
soma in these neurites, compared to CaV2.2e37b (Fig. 3E). In sum-
mary, CaV2.2e37a channels in the DRG neurons were trafficked fur-
ther along the neurites, as well as to the plasma membrane of the cell
bodies, to a significantly greater degree than CaV2.2e37b channels.
2-1 is essential for the underlying mechanism of
differential CaV2.2 isoform trafficking
Auxiliary 2 subunits play an important role in CaV2.2 traffick-
ing (Dolphin, 2012; Cassidy et al., 2014). To determine whether
2-1 is required for the differential cell surface expression of
CaV2.2e37a channels, HA-tagged CaV2.2e37 isoforms were coex-
pressed plus 1b, with or without 2-1 in tsA-201 cells. The
average whole-cellGmax for both isoforms in the absence of2-1
was significantly reduced, and the difference in conductance be-
tween e37a and e37b was lost (Fig. 4A,B). Similarly, in N2a cells,
immunostaining of the cell surface HA-CaV2.2 revealed that the
increased plasma membrane expression of CaV2.2e37a, relative
to CaV2.2e37b, was lost in the absence of2-1 (Fig. 4C,D). Thus,
2-1 is required for underlying mechanisms involved in the
differential trafficking of CaV2.2e37a, possibly via interaction
through intermediate protein(s) and utilization of the same path-
way(s) involved in transporting the channels to the plasma
membrane.
CaV2.2e37a shows greater net forward trafficking to the
cell membrane
To investigate the mechanism of differential CaV2.2 splice variant
trafficking, BBS-tagged CaV2.2 constructs were expressed in N2a
cells, in which the channels can be live-labeled directly with
Figure 2. CaV2.2e37a exhibits a greater cell surface expression compared to CaV2.2e37b.A, Top, A schematic diagram showing GFP-HA-tagged CaV2.2, which contains GFP at the N terminus and
HAgHA in an extracellular loop. Bottom, Confocal images of N2a cells expressing GFP-HA-CaV2.2e37a and e37b with2-1 and1b. Scale bar, 20m. B, Normalized cell surface (left) and total
(right) CaV2.2 of GFP-HA-CaV2.2e37 isoforms. Cell surface HA and total GFP fluorescence intensities were quantified and normalized to the average intensity value of CaV2.2e37b from each
experiment. Cell surface expression of GFP-HA-CaV2.2e37a was significantly greater than that of e37b ( p 0.0174). C, Cell surface (left) and total (right) CaV2.2 levels for HA-CaV2.2 isoforms,
expressed in arbitrary units. Cell surface expression of HA-CaV2.2e37awas significantly greater than that of e37b ( p 0.0050), and the GFP at the N terminus did not affect the trafficking patterns
for CaV2.2e37 isoforms. n, Number of cells. *p	 0.05; **p	 0.01 (Student’s unpaired t test).
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BTX488, to monitor the net appearance of the channels in the
plasma membrane over time, after saturating the channels al-
ready on the surface with unlabeled BTX (Fig. 5A). In this proto-
col, the initial rate of appearance of CaV2.2e37a on the cell surface
was greater than for CaV2.2e37b, leading to a greater steady-state
maximum cell surface expression level (Fig. 5B). These results
imply that the increased presence of CaV2.2e37a on the cell sur-
face is due to an increased trafficking from subcellular organelles
to the plasma membrane. Since the AP binding motifs in the
CaV2.2e37 isoforms are also recognized by AP-2, another mem-
Figure 3. CaV2.2e37a is trafficked more readily than CaV2.2e37b to the plasma membrane of the soma and to the neuronal processes of DRG neurons. A, Confocal images of DRG cell bodies
expressing GFP-HA-CaV2.2 isoforms with2-1 and1b. B, Normalized cell surface and total CaV2.2 in cell bodies. The cell surface HA and total GFP fluorescence densities were quantified and
normalized to the average intensity value of CaV2.2e37b from each experiment. Cell surface expression of GFP-HA-CaV2.2e37a in the DRG somata was significantly greater than that of e37b ( p
0.0277). C, Confocal images of DRG neurites expressing GFP-HA-CaV2.2 isoforms with free mCherry. D, Total fluorescence of CaV2.2 isoforms and free mCherry in the neurites (in10
7 a.u.). Total
GFP-HA-CaV2.2e37a in the DRG neurites was significantly greater than e37b ( p 0.0038). E, Total length of DRG neurites showing expression of GFP-HA-CaV2.2e37 isoforms. CaV2.2e37a channels
were expressed further away from the soma than e37b channels ( p 0.0436). Scale bars: A, C, 20m. n, Number of cells. *p	 0.05; **p	 0.01 (Student’s unpaired t test).
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ber of the AP family that is involved in endocytosis, the basal rates
of endocytosis of the two isoforms were compared. CaV2.2e37a
and CaV2.2e37b showed similar kinetics of endocytosis (Fig.
5C,D, Table 2), indicating that this did not contribute signifi-
cantly to the observed differences in net forward trafficking.
Brefeldin A reduces cell surface expression of CaV2.2
splice variants
The two main sources of transmembrane proteins inserted
into the plasma membrane are (1) newly synthesized proteins
from the endoplasmic reticulum (ER) and the Golgi apparatus
(Guo et al., 2014) and (2) recycled proteins via recycling endo-
somes (Grant and Donaldson, 2009). BFA, which disrupts the
structure of the Golgi apparatus and inhibits the translocation of
proteins from the ER to the plasma membrane (Fujiwara et al.,
1988; Lippincott-Schwartz et al., 1989), was then used to further
elucidate the mechanism of differential CaV2.2e37a net forward
trafficking. As expected, in the presence of BFA, the maximum
level of CaV2.2 splice variants appearing on the plasma mem-
brane was markedly reduced compared to the control condition
(Fig. 5D). This shows that approximately half of the channel
population at the plasma membrane originated from the recy-
cling endosomes within the duration of these experiments. Fur-
thermore, in the presence of BFA, the difference between
CaV2.2e37a and CaV2.2e37b in the maximum cell surface level
achieved was abolished. In addition, the kinetics of CaV2.2e37a
net trafficking to the plasma membrane were markedly slowed
compared to those in the absence of BFA (Fig. 5E). BFA inhibits
ADP ribosylation factor 1 (Arf1), which is essential for the re-
cruitment of AP-1, which mediates clathrin-dependent cargo
sorting (Zhu et al., 1998; Ren et al., 2013). These observations
raised the possibility that the greater forward trafficking and in-
creased cell surface expression of CaV2.2e37a, relative to
CaV2.2e37b, are due to differences in sequence of the proximal C
terminus of CaV2.2 as a result of alternative splicing, and that the
underlying mechanism may involve AP-mediated sorting.
AP-1 expression knockdown and the AP-1V98S dominant-
negative mutant impair the cell surface expression of CaV2.2
isoforms
Members of the AP family play an important role in clathrin-
mediated cellular sorting of protein cargoes (Bonifacino and Traub,
2003). AP-1 is involved in cargo sorting in the Golgi apparatus, via
interaction between its1 (AP-1) subunit and Yxxmotifs, where
Figure 4. Effect of2-1 on the whole-cell conductance and the cell surface expression of CaV2.2 isoforms. A, Average whole-cell current density of CaV2.2 isoforms with andwithout2-1 in
tsA-201 cells [peak current density (pA/pF), e37b2-1 (blue),204.5 22.9 (10mV, n 12); e37b (cyan),41.7 19.1 (15mV, n 6); e37a2-1 (red),323.0 46.8 (5
mV, n 10); e37a (pink),35.2 10.0 (15 mV, n 6)]. B, Gmax. Values for experiments shown in A. C, Confocal images of N2a cells expressing HA-CaV2.2 isoforms, with or without2-1.
Scale bar, 20m.D, Cell surface CaV2.2 levels. The HA fluorescence intensities were normalized to the average intensity of CaV2.2e37b from each experiment. n, Number of cells. *p	 0.05; **p	
0.01; ***p	 0.001 (one-way ANOVA, Bonferroni’s post hoc test).
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Figure 5. The forward trafficking of CaV2.2e37a isoforms is reduced by BFA. A, Confocal images of N2a cells expressing BBS-tagged CaV2.2e37 isoforms at different time points after the start of
the net forward trafficking assay, showing the appearance of CaV2.2 at the cell surface by BTX488 live labeling.B, Left, Kinetics of CaV2.2e37 isoform net forward trafficking. The kinetic curves were
fitted to a single exponential to derive time constant (minutes). The rates of net forward trafficking (1/, inmin1)were as follows: e37a (red), 0.2120.027 (n3); e37b (blue), 0.1320.036
(n 3 transfections). As a negative control (blue open circle), e37bwas kept at 4°C after the start of the experiment. Right, The initial rates of net forward trafficking of CaV2.2 isoforms in N2a cells
were determined by taking the gradient of the linear regression from the initial linear phase of each forward trafficking kinetic curve. [CaV2.2e37b (blue), 116.6 3.1 a.u./min; CaV2.2e37a (red),
207.7 20.3 a.u./min; n 3 transfections]. *p 0.0114 (Student’s unpaired t test). C, Endocytosis of CaV2.2e37 isoforms and AP-binding mutants. Representative confocal images of N2a cells
expressing BBS-tagged CaV2.2e37 isoforms at different time points after the start of an endocytosis assay, showing the disappearance of BTX488-labeled CaV2.2 from the cell surface. D, The
endocytosis kinetics of CaV2.2e37 isoforms. All cell surface intensities were normalized to CaV2.2e37b at t 0min in each experiment. The time constants () from fitting a single exponential were
as follows (inmin): e37a (red), 7.00 1.23; e37b (blue), 11.6 3.53 (n 3 transfections). e37b (open blue circle) was kept at 4°C as a negative control after the start of endocytosis experiment.
E, Left, Kinetics of CaV2.2e37 isoform net forward trafficking in the presence of BFA (open red circle, e37a BFA; open blue circle, e37bBFA). Controls without BFA at 60 min are also shown for
each isoform (red circle, 37a; blue circle, 37b). Right, The net forward trafficking rate of CaV2.2e37a isoforms with andwithout BFA. The time constants () of the single exponentials from Figure 5,
B and E were determined, and the rates were obtained by the reciprocal of  (1/) (red closed bar, CaV2.2e37a; red open bar, CaV2.2e37a BFA; blue closed bar, CaV2.2e37b; blue open bar,
CaV2.2e37b BFA; n 3 transfections). *p	 0.05 (one-way ANOVA, Bonferroni’s post hoc test). Scale bars: A, C, 20m.
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 is hydrophobic residue I, L, M, F, or V (Ohno et al., 1995), and
interaction of the -1 hemicomplex (AP-1) with [DE]xxxL[LI]
motifs (Janvier et al., 2003). We noted that both these canonical
motifs (Yxx and [DE]xxxL[LI]) are present in the e37a sequence
DMYSLL (Fig. 1A), supporting the possibility of interaction with
APs. Interestingly, Cav2.2e37a contains both motifs in an overlap-
ping manner, whereas CaV2.2e37b contains only a noncanonical
[DE]xxxL[LI] motif where LL is substituted by ML (Motta et al.,
1995; Hofmann et al., 1999). BFA disrupts AP-1-mediated sorting in
the Golgi network, and the reduction in the maximum level of
CaV2.2 detected at the plasma membrane in the presence of BFA
implicated a role for AP-1 in CaV2.2 trafficking to the plasma
membrane.
To examine the involvement of AP-1 in CaV2.2 trafficking,
AP-1 shRNA was coexpressed with HA-tagged CaV2.2e37 isoforms
to knock down the expression of the key subunit for AP-1 interac-
tion with [DE]xxxL[LI] (Cheung and Cousin, 2012). The cell surface
CaV2.2 levels were compared to a control in which scrambled AP-1
shRNA was coexpressed. AP-1 shRNA reduced the AP-1 (or
-adaptin) expression level by50% (Fig. 6A) and caused a modest
but significant reduction in the cell surface expression of both
CaV2.2e37 isoforms (Fig. 6B). To confirm the interaction between
AP-1 and CaV2.2, the AP-1 dominant-negative mutant V98S was
coexpressed with the CaV2.2e37 isoforms in N2a cells, to impair the
interaction with [DE]xxxL[LI]. This construct has been shown to
disrupt the somatodendritic trafficking of the cargoes in hippocam-
pal neurons (Jain et al., 2015). AP-1V98S significantly reduced the
cell surface expression of both CaV2.2e37 isoforms by50%, rela-
tive to those that were coexpressed with the wild-type AP-1 (Fig.
6C,D). The disrupted trafficking of both CaV2.2 isoforms, as a result
of the impairment of AP-1 function, suggests that trafficking of both
isoforms is mediated by AP-1 and that the noncanonical DxxxML
motif in CaV2.2e37b may also function, albeit less efficiently, as an
AP-1 binding motif and be involved in trafficking to the plasma
membrane.
Mutations in AP binding motifs in the C terminus of
CaV2.2e37a reduce the cell surface expression and the whole-
cell currents through CaV2.2
Since the CaV2.2e37a sequence contains both Yxx and
[DE]xxxL[LI] motifs, we mutated key residues to identify which
motif is important in AP-1 interaction and to elucidate the mech-
anism of CaV2.2 channel trafficking. In total, 4 CaV2.2e37a mu-
tants were created, mutating DMYSLL to DMASLL (Y/A),
DMYSAL (L/A), DMYSAA (LL/AA), and DMASAA (YSLL/
ASAA) (Fig. 7A). The L/A mutant is only able to interact with
AP-1, and the Y/A mutant can only interact with AP-1,
whereas the LL/AA and YSLL/ASAA mutants completely abolish
the interaction with AP-1 via these motifs. The cell surface and
whole-cell expression levels of these four mutants and the wild-
type CaV2.2e37a (all coexpressed with 2-1 and 1b) were de-
termined by Western blot and immunocytochemistry (Fig.
7A,B). The plasma membrane expression levels of the L/A and
Y/A mutants were 50% of the WT, and the LL/AA and YSLL/
ASAA mutants were almost undetectable at the cell surface (Fig.
7B,C, left), despite the intracellular expression levels of all mu-
tants showing no significant difference relative to the WT
CaV2.2e37a (Fig. 7C, right). The overall expression levels of these
mutants were also similar with each other in the Western blot, but
slightly reduced particularly for the YSLL/ASAA mutant com-
pared to the WT, although the reduction was not statistically
significant (Fig. 7A). This may reflect the smaller number of cells
in which intracellular CaV2.2 expression was detected in N2a
cells, particularly for this mutant, as mutations in these motifs
can lead to missorting of the proteins, which are then degraded
(Braulke and Bonifacino, 2009). We therefore took the L/A, Y/A,
and LL/AA mutants forward to further investigate the function
and trafficking of these mutants.
To investigate whether the reduced plasma membrane expres-
sion of these CaV2.2 mutants leads to a parallel reduction in func-
tion, we recorded the whole-cell current of the L/A, Y/A, and
LL/AA mutants expressed in tsA-201 cells in the presence of
2-1 and 1b. No current was detected from the LL/AA mutant
(Fig. 7D), as predicted from the imaging experiments (Fig. 7C).
The L/A and Y/A mutations caused the CaV2.2 peak currents and
Gmax to be significantly reduced, compared to the WT
CaV2.2e37a (Fig. 7D,E). The V50 activation voltages were not
altered for these mutants (Fig. 7F). These results demonstrate
that AP interaction is involved in the trafficking of CaV2.2e37a to
the cell surface in the presence of the auxiliary subunits, and the
reduced cell current density is due to the lower density of chan-
nels in the plasma membrane.
Expression of CaV2.2 AP-1 binding motif mutants in DRG
neurons is reduced at the plasmamembrane of the soma and
in the neurites as a result of diminished net forward
trafficking
To confirm that the mutations in the AP-1 binding motifs at the
proximal C terminus of CaV2.2 have an effect on channel traffick-
ing in neurons, these mutant CaV2.2 channels were also tagged
with GFP at the N terminus. DRG neurons were transfected with
HA-tagged GFP-CaV2.2 mutants in the presence of 2-1 and
1b (Fig. 8A). Immunostaining for HA revealed that in the cell
bodies of DRG neurons, expression of all mutants at the plasma
membrane was reduced, particularly for the LL/AA mutant, with-
out significantly affecting the total expression levels of the chan-
nels (Fig. 8B). Furthermore, a significantly lower level of these
mutants was observed in the neurite compartment, and expres-
sion in neurites was confined much closer to the cell bodies,
relative to WT (Fig. 8C–E), suggesting that these motifs are cru-
cial for CaV2.2 trafficking along the neurites as well.
The L/A and Y/A mutants were also tagged with the exofa-
cial BBS tag to investigate how these mutations affect intracel-
lular trafficking of CaV2.2e37a. The appearance of the mutant
channels on the plasma membrane was significantly slower
than for WT CaV2.2e37a, leading to a reduction in the maxi-
mum density of cell surface channels (Fig. 8F ). The slower
overall rates of forward trafficking kinetics for these mutants,
compared to WT CaV2.2e37a (Fig. 8F, inset), were similar to
that for WT CaV2.2e37a in the presence of BFA (Fig. 5E).
Table 2. Effect of D2R activation on rate of endocytosis of CaV2.2e37 splice variants
andmutants
 (min)
Quin 0 nM 100 nM
37a 7.00 1.23 (3) n/a
37a D2R 11.1 1.43 (5) 6.60 0.22 (3)
37b 11.6 3.53 (3) n/a
37b D2R 29.0 4.89 (4) 6.90 0.36 (3)
37a L/A 13.8 1.85 (4) n/a
37a L/A D2R 27.3 4.43 (3) 18.6 1.62 (3)
37a Y/A 21.1 3.53 (4) n/a
37a Y/A D2R 12.6 2.20 (3) 7.28 0.90 (3)
The endocytosis time constants () for CaV2.2 splice variants 37a and 37b and the 37a mutants, either alone or in
combination with the D2R, are shown. When the D2R was included, experiments were performed in the absence
(middle) or presence (right) of the D2R agonist Quin (100 nM). Number of different separate experiments are given
in parentheses, with at least 20 cells per time point for each experiment.
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Furthermore, the average time constant for endocytosis
was approximately doubled for the CaV2.2e37a L/A mutant,
and more than tripled for the Y/A mutant, compared to WT
CaV2.2e37a (Fig. 8G, Table 2). This observation could be ex-
plained by the action of AP-2, which is also able to recognize
and interact with both Yxx and [DE]xxxL[LI] and predom-
inantly mediates clathrin-dependent endocytosis (Nesterov
et al., 1999; Motley et al., 2003). It is therefore possible
that the Yxx motif plays a more dominant role than the
[DE]xxxL[LI] motif in AP-2-mediated endocytosis of
CaV2.2e37a. In summary, AP binding motifs at the C terminus
of CaV2.2 control the intracellular trafficking of CaV2.2, and
mutations to these sites disrupt the trafficking to the cell sur-
face and to the distal ends of neurites.
Effect of D2R coexpression and activation on trafficking of
CaV2.2 splice variants
We next examined whether CaV2.2 endocytosis stimulated by
activation of GPCRs would be differentially affected for the
CaV2.2e37 isoforms. Previous studies demonstrated that both D1
Figure 6. AP-1 knockdown and the dominant-negative AP-1 mutant reduce CaV2.2 trafficking to the plasmamembrane. A, Knockdown of AP-1 (or-adaptin) by AP-1 shRNA. AP-1 shRNA
expressed in N2a cells reduced the -adaptin expression level by44%, compared to the -adaptin expression level in the scrambled shRNA condition. The expression of shRNA detected by
mCeruleanwas comparable in all conditions (scrambled shRNA, closedbar,n56; AP-1 shRNA, openbar,n59;p	0.0001).B, AP-1 shRNA significantly reduces cell surface expression of both
CaV2.2e37 isoforms. Cell surface CaV2.2 was normalized to the scrambled AP-1 shRNA control condition in each experiment. The expression of shRNA detected by mCerulean was comparable in
all conditions (CaV2.2e37a, p 0.0271; CaV2.2e37b, p 0.0049). C, Confocal images of BBS-tagged CaV2.2e37b showing reduced cell surface expression (second panel) in the presence of AP-1
V98S, compared to WT. Scale bar, 20m. D, Dominant-negative AP-1 V98S mutant significantly reduces cell surface CaV2.2e37 isoforms. Cell surface CaV2.2 was normalized to the wild-type
AP-1 control condition in each experiment. The expression level ofmyc-taggedAP-1detected by anti-myc antibodywas comparable in all conditions (CaV2.2e37a, p	0.0001; CaV2.2e37b,p	
0.0001). n, Number of cells. *p	 0.05; **p	 0.01; ***p	 0.001 (Student’s unpaired t test).
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and D2 dopamine receptors directly interact with CaV2.2 via in-
tracellular regions to modulate the channel properties, cell sur-
face expression, and endocytosis (Kisilevsky and Zamponi, 2008;
Kisilevsky et al., 2008). We therefore coexpressed the CaV2.2e37
isoforms (with2-1 and1b), together with D2R in N2a cells, to
first determine the effect of D2R on cell surface expression of
the two CaV2.2e37 isoforms. We found that D2R had no effect
on the cell surface expression of CaV2.2e37a, and modestly en-
Figure 7. Effect of site-directed mutagenesis in adaptor protein binding motifs in CaV2.2e37a sequence. A, Left, Western blot analysis of CaV2.2e37a AP-binding mutants. Full-length CaV2.2 is
detected in thewhole-cell lysates (20gper lane) of tsA-201 cells expressingAP-bindingmutantswith2-1 and1b. In theuntransfectednegative control (U/T), cellswere transfectedwithGFP.
GAPDH staining shows equal protein loading in all lanes. Right, Quantification of band intensities of theWestern blots. The intensities of CaV2.2e37a AP-bindingmutants were normalized against
theWT in each experiment after the background subtraction. The protein expression of CaV2.2e37aAP-bindingmutants andWTswas not significantly different (n 4).B, Confocal images showing
N2a cells expressing HA-tagged AP-binding mutants. Scale bar, 20m. C, Cell surface expression of AP-binding mutants. The values were normalized to the average HA fluorescence intensity of
wild-type CaV2.2e37a (WT) from each experiment. Left, Cell surface: red, WT (n 64); purple, L/A (n 82); pink, LL/AA (n 43); green, Y/A (n 94); yellow, YSLL/ASAA (n 7). Right, Total
CaV2.2 levels were not significantly different in all conditions. Only a few cells that were expressing CaV2.2 from YSLL/ASAAmutation were detected, due to a low expression of CaV2.2 in N2a cells.
D, Whole-cell current density of AP-bindingmutants. The peak current densities at0mV are as follows (in pA/pF); WT (red),185.7 28.7 (n 24); L/A (purple),103.2 12.8 (n 27);
Y/A (green),101.9 18.3 (n 30); LL/AA (pink), 2.44 0.34 (n 4).E,Gmax of AP-bindingmutants is also significantly reduced, similarly to the cell surface expression.F,V50,act of CaV2.2e37a
AP-1 binding mutants. V50 activation was not altered by the mutations [p 0.27; WT (red), n 22; L/A (purple), n 27; Y/A (green), n 30]. n, Number of cells. *p	 0.05; ***p	 0.001
(one-way ANOVA, Bonferroni’s post hoc test).
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hanced the cell surface expression of CaV2.2e37b (Fig. 9A). Fur-
thermore, upon D2R activation by the specific agonist Quin, the
amount of both Cav2.2e37 isoforms on the cell surface was sig-
nificantly reduced by30% relative to the control within 30 min
(Fig. 9B,C), which is likely to represent endocytosis. To elucidate
the differential effect of D2R on the CaV2.2e37 isoform cell sur-
face expression, the rate at which these channels undergo endo-
cytosis with D2R was determined using BBS-tagged CaV2.2e37
Figure 8. CaV2.2 AP-1 binding motif mutants exhibit reduced trafficking to the cell surface of DRG soma and to DRG neurites. A, Confocal images of DRG somata expressing GFP-HA-tagged
CaV2.2e37a AP-binding mutants. B, Cell surface expression of AP-binding mutants. The values were normalized to the average HA fluorescence intensity of wild-type CaV2.2e37a from each
experiment. Normalized total GFP fluorescence intensities in the cell were not significantly different ( p 0.14). C, Confocal images of DRG neurons expressing GFP-HA-tagged CaV2.2e37a
AP-bindingmutants with freemCherry in the neuronal processes. GFP is also expressed in some nonneuronal cells.D, Total fluorescence of GFP-HA-CaV2.2 AP-bindingmutants and freemCherry in
the DRG neurites (in10 7 a.u.). The total mCherry fluorescence values in the neurites were not significantly different ( p 0.14). E, Total length of DRG neurites expressing GFP-HA-CaV2.2
AP-bindingmutants andWT. TheAP-bindingmutantswere expressed in neurites significantly closer to the soma than theWT.F, The net forward trafficking kinetics of CaV2.2 AP-1 bindingmutants.
Net forward trafficking rates in the inset are as follows (in min1): WT (red), 0.212 0.027 (from Fig. 4B); L/A (purple), 0.048 0.009; Y/A (green), 0.045 0.008 (n 3 to 5 transfections). G,
The endocytosis kinetics of CaV2.2 AP-bindingmutants. Cell surface L/A (purple) and Y/A (green)mutantswere normalized to theWTat t 0min (red) in each experiment. The inset shows the time
constants  (in min): L/A (purple), 13.8 1.85; Y/A (green), 21.1 3.53 (n 3 to 4 transfections). Scale bars: A, C, 20m. n, Number of cells. *p	 0.05; **p	 0.01; ***p	 0.001 (one-way
ANOVA, Bonferroni’s post hoc test).
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Figure 9. Effect of D2R expression and activation on cell surface CaV2.2e37 isoforms. A, Left, Confocal images of N2a cells expressing HA-tagged CaV2.2 with or without D2R. Scale bar, 20m.
Right, Cell surface CaV2.2with D2R is normalized to the control condition expressing an empty vector in each experiment. D2R significantly increased cell surface CaV2.2e37b ( p 0.0064), whereas
cell surface CaV2.2e37awas not affected by D2R ( p 0.85).B, Left, Cell surface CaV2.2e37b in the presence of D2R,with orwithout 100 nMQuin ( p 0.0067).Middle, CaV2.2e37b endocytosis rate
was slowed by the presence of D2R and accelerated by D2R activation (closed blue circle, e37bD2R; open blue circle, e37bD2RQuin; black circle, e37b; from Fig. 5D). Right, The endocytosis
kinetics (black bar, e37b; closed blue bar, e37b D2R; open blue bar, e37b D2R Quin; n 3 to 5 transfections; p	 0.05, one-way ANOVA, Bonferroni’s post hoc test). C, Left, Cell surface
CaV2.2e37a in thepresence ofD2R,with orwithout 100nMQuin ( p0.0002).Middle, e37a endocytosiswasnot significantly changedby thepresence ofD2Rnor byD2Ractivation (closed red circle,
e37a D2R; open red circle, e37a D2R Quin; black circle, 37a; from Fig. 5D). Right, The endocytosis kinetics (black bar, e37a; closed red bar, e37a D2R; open red bar, e37a D2R Quin;
n3 to 5 transfections).D, Cell surface CaV2.2 in thepresence of D2R,with orwithout 100nMQuin after PTX treatment (37b,p0.0019; 37a,p0.0302).E, PTXblocks CaV2.2 inhibitionmediated
byD2R activation. PTX treatment removed the inhibition of CaV2.2whole-cell current by 100 nMQuin application to activate D2R [CaV2.2e37b control (blue closed squares), n 23; CaV2.2e37bwith
PTX (blue open triangles), n  10; CaV2.2e37a control (red closed squares), n  22; CaV2.2e37a control (red open triangles), n  3]. F, Cell surface CaV2.2 in the presence of D2R and
dominant-negative AP-22mutant F174A/D176S,with orwithout 100 nMQuin (37b, p 0.2877; 37a, p 0.7246).G, Endocytosis of CaV2.2e37a L/A and Y/Amutantswas not accelerated by D2R
activation. The endocytosis kinetics are shown for L/AD2R (closed purple circle) and L/AD2RQuin (open purple circle) in the left panel and Y/AD2R (closed green circle) and Y/AD2R
 Quin (open green circle) in the right. For all experiments, n 3 to 5 transfections. n, Number of cells. *p	 0.05; **p	 0.01; ***p	 0.001 (Student’s unpaired t test).
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isoforms in the presence or absence of Quin, and these rates were
compared with the previously determined basal endocytosis
without D2R (Fig. 5D, Table 2). The endocytosis rate of
CaV2.2e37b was significantly slowed by the presence of D2R (Fig.
9B, Table 2). CaV2.2e37b then internalized more rapidly in the
presence of Quin, with a  value similar to that determined for
CaV2.2e37b alone. On the other hand, the basal endocytosis rate
of CaV2.2e37a was not significantly affected by coexpression of
D2R, compared to CaV2.2e37a alone (Fig. 9C, Table 2), as pre-
dicted from the previous comparison of cell surface expression
levels (Fig. 9A). In contrast to the effect of Quin to reduce the
overall cell surface expression of CaV2.2e37a channels, Quin
treatment did not significantly accelerate CaV2.2e37a endocyto-
sis, possibly reflecting a minimum limit in the determination of
endocytosis rate by this protocol.
This effect of Quin was not blocked by pretreatment with PTX
(Fig. 9D), indicating that D2R activity-mediated endocytosis is
independent of the direct action of G on CaV2.2, as PTX blocks
voltage-dependent inhibition of CaV2.2 by Quin (Fig. 9E). Re-
ceptor sequestration has been reported for a number of GPCRs
following activation, which is mediated by the recruitment of
-arrestin to the activated receptor (Krupnick and Benovic,
1998). -arrestin targets GPCRs for clathrin-dependent endocy-
tosis by directly interacting with AP-2 (Goodman et al., 1996;
Zhang et al., 1996; Laporte et al., 1999, 2000). To test whether
blocking clathrin-mediated endocytosis also inhibits D2R
activation-induced CaV2.2 endocytosis, the dominant-negative
mutant of the AP-22 subunit F174A/D176S was coexpressed;
this construct has been shown to impair transferrin endocytosis
(Motley et al., 2006). In the presence of the AP-22 mutant,
CaV2.2 endocytosis was not observed after Quin treatment (Fig.
9F). To confirm the involvement of AP-2 in D2R-mediated en-
docytosis of CaV2.2, the endocytosis rates of CaV2.2e37a L/A and
Y/A mutants with D2R were examined. Quin treatment did not
alter the endocytosis of either mutant (Fig. 9G, Table 2). These
results indicate that disrupting the interaction between AP-2 and
CaV2.2 blocks D2R agonist-induced endocytosis. In summary,
these data suggest that (1) the D2R has a differential effect on
CaV2.2e37 isoforms at the cell surface, as it reduces the endocy-
tosis rate of CaV2.2e37b, but not e37a, and (2) activation of
the D2R causes both CaV2.2e37 isoforms to internalize via
-arrestin-mediated recruitment of clathrin, which requires in-
teraction between AP-2 and CaV2.2.
Discussion
AP-1 mediated regulation of CaV2.2 splice variant trafficking
CaV2.2 trafficking is mediated by interaction with its auxiliary
subunits and various intracellular proteins (Kaeser et al., 2011;
Dolphin, 2012). Our data demonstrate enhanced trafficking of
CaV2.2e37a compared to the e37b splice variant, both to the
plasma membrane and to neuronal processes where these chan-
nels are physiologically important. The 37a exon contains inter-
action motifs for both the 1 subunit and -1 hemicomplex of
AP-1, which are overlapping (DMYSLL). However, an AP-1
complex would be unable to bind both simultaneously due to
conformational constraints (Heldwein et al., 2004; Ren et al.,
2013). The complete abolition of both motifs severely disrupted
trafficking of CaV2.2e37a to the cell membrane and DRG neu-
rites, demonstrating the importance of these AP-1 interaction
sites in the proximal C terminus of CaV2.2. Furthermore,
[DE]xxxL[LI] is also present in other voltage-gated calcium
channels such as CaV1.3, 1.4 and CaV2.1(e37a) in the proximal C
terminus (Table 3). On the other hand, the CaV2.2e37b splice
variant has a noncanonical [DE]xxxL[LI] motif, where L[LI] is
substituted by ML (DMEFML), which is indicated to be a less
efficient signal compared with the canonical motif (Motta et al.,
1995; Hofmann et al., 1999). In addition, the e37b sequence lacks
Yxx. This may explain why CaV2.2e37b channels are less effi-
ciently trafficked to the plasma membrane and to the DRG neu-
rites, compared to CaV2.2e37a, which contains two strong signals
for binding to AP-1 in this exon. Mutating CaV2.2e37a from
DMYSLL to DMFSLL also reduced the current density, which
was indistinguishable from that of CaV2.2e37b (Raingo et al.,
2007), supporting this hypothesis.
The proximity of these motifs in the C terminus of CaV2.2
to the membrane may also create a favorable site for AP-1
interaction. This has been demonstrated for AP-2, which is
recruited to the plasma membrane via phosphatidylinositol
4,5-bisphosphate interaction. This causes AP-2 to undergo a
“locked” to “open” conformational change, which exposes its
motif-binding sites (Jackson et al., 2010). Although phospho-
inositides such as phosphatidylinositol 4-phosphate, preva-
lent in the Golgi, are alone insufficient for the recruitment of
AP-1, the close proximity of these motifs to the membrane is
probably important, as membrane-associated Arf1 brings
AP-1 close to the Golgi membrane, where it unlocks the AP-1
conformation to allow for cooperative binding of the cargo
and phosphatidylinositol 4-phosphate (Stamnes and Roth-
man, 1993; Crottet et al., 2002; Ren et al., 2013).
The overlapping nature of the AP-1 binding motifs in
CaV2.2e37a is unprecedented; however, abolishing either of
the binding sites for AP-11 and -1 in CaV2.2e37a, by mu-
tating the key amino acids, led to a partial loss of cell surface
expression and trafficking to the DRG neurites. This indicates
that both of the AP-1 subunits separately have the ability to
interact with the overlapping motif in e37a and are able to
partially compensate for the trafficking defect in the e37a sin-
gle mutants, when only one of the potential binding sites is
available. However, when both motifs are available for inter-
action, one of the AP-1 subunits may have a higher affinity
than the other toward its corresponding motif, to mediate
more efficient trafficking in a native state. Moreover, other
intracellular regions of CaV2.2 also contain possible interac-
tion sites for APs. For example, there is one Yxxmotif in the
N terminus (Y59) and two in the II–III loop (Y811 and Y1154),
whereas there is only one other [DE]xxxL[LI] site, which is in
the distal C terminus (E2256) in CaV2.2. All of these sites are
conserved in human, mouse, rat, rabbit, and chicken CaV2.2.
In the case of AP-2, binding to [DE]xxxL[LI], Yxx, and
phosphatidylinositol 4,5-bisphosphate is essential for ensur-
ing its high affinity for the cargo in the membrane (Jackson et
al., 2010). CaV2.2e37a may be able to present both motifs in
the e37a sequence to the AP-1 complex studied here, and as a
result the AP-1 complex is able to interact with the conforma-
tionally most favorable counterpart motif for mediating effec-
tive trafficking. No mutational or interaction studies have
been conducted on the other sites in Cav2.2 so far, and it will
Table 3. DExxxLLI and Yxxmotifs in the C-terminus of CaV channels
CaV1.2 GRIKHLDVVTLLRRIQ
CaV1.3 GRIKHLDVVTLLRRIQ
CaV2.1 (e37a) GRIHYKDMYSLLRVIS
CaV2.1 (e37b) GRMPYLDMYQMLRHMS
CaV2.2 (e37a) CRIHYKDMYSLLRCIA
CaV2.2 (e37b) GRISYNDMFEMLKHMS
The DExxxLLI and Yxxmotifs in the proximal C-terminus of CaV channels are indicated in bold.
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now be important to investigate the involvement of these sites
in AP-mediated trafficking.
Although it is not clear which AP-1 subunit mediates traffick-
ing more effectively in the native state, it has been shown for
AP-2 that it interacts with Yxx with a higher affinity than
[DE]xxxL[LI] (Jackson et al., 2010). This was also found in our
experiments where the CaV2.2e37a Y/A mutant showed a mark-
edly slower endocytosis rate, indicating that the Yxxmotif may
also interact with AP-22 subunits, which are involved predom-
inantly in clathrin-mediated endocytosis (Nesterov et al., 1999).
Our findings suggest that in the case of endocytosis, Yxx may
play a more important role than [DE]xxxL[LI] in mediating
CaV2.2 endocytosis.
Both shRNA knockdown of AP-1 and expression of the
dominant-negative AP-1 mutant V98S reduced trafficking of
both isoforms to the plasma membrane. This provides direct
evidence for AP-1 mediating trafficking for both isoforms of
CaV2.2, e37a and e37b. Although other possible AP-interaction
sites mentioned above potentially mediate CaV2.2 trafficking, the
differential trafficking observed between the e37 isoforms in this
study suggests that this particular motif may play a more impor-
tant role than the others. Nevertheless, incomplete inhibition
suggests that CaV2.2 trafficking may also involve non-clathrin-
mediated mechanisms, such as lipid raft- and caveolae-mediated
trafficking (Le Roy and Wrana, 2005; Parton and Simons, 2007).
Indeed, CaV2 channels colocalize with caveolin and flotillin-1 in
the presence of  and 2 subunits, and are present in lipid rafts
(Davies et al., 2006; Robinson et al., 2010). Overexpression
studies of AP-1 dominant-negative mutants have indicated
previously that AP-1 mediates somatodendritic trafficking of
transmembrane receptors in central neurons such as hippocam-
pal neurons (Farías et al., 2012; Jain et al., 2015). Our CaV2.2e37a
AP-1 binding site mutants demonstrate that AP-1 may also play
an important role in axonal trafficking in DRG neurons, since
these are pseudounipolar and do not form dendrites, and there-
fore binding of AP-1 to these sites may modulate the presence of
these channels at the presynaptic membrane.
Interaction between CaV2.2 splice variants and dopamine
receptors and effects of receptor activation
Direct interaction between CaV2.2 and dopamine receptors may
be important in regulating the surface expression of CaV2.2 (Kisi-
levsky and Zamponi, 2008; Kisilevsky et al., 2008). We find in N2a
cells that coexpression of D2R does not increase the cell-surface
expression of CaV2.2e37a and produces only a modest increase
for CaV2.2e37b. Our results show that the rate of endocytosis of
CaV2.2e37b is considerably slowed by the D2R; thus, the channels
are more stable and they accumulate at the cell surface. Surpris-
ingly, this stabilizing effect at the plasma membrane diminishes
upon D2R activation, and CaV2.2e37b internalizes at an in-
creased rate similar to that for the channel expressed in the ab-
sence of the receptor.
There are two possible explanations for this observation: (1)
the activated D2R-CaV2.2 complex internalizes together at an
accelerated rate; (2) the activated D2R undergoes a conforma-
tional change and dissociates from CaV2.2 at the cell surface, and
they internalize separately at their own native rates. How D2 re-
ceptors decrease the endocytosis rate of CaV2.2e37b channels is
still not clear; however, the colocalization of CaV2.2 and D2R via
direct interaction of their intracellular regions suggested previ-
ously (Kisilevsky and Zamponi, 2008) implies that APs may be
able to bind to the cargo motifs in CaV2.2 and D2R simultane-
ously to regulate their cotrafficking. Indeed, the D2R contains
Yxx motifs in its intracellular loops 2 and 3 near the plasma
membrane, but does not contain [DE]xxxL[LI] (Namkung and
Sibley, 2004). In the case of endocytosis, the AP-2  subunit
could potentially interact with either of these Yxx motifs in
D2R, whereas the AP-2 -2 hemicomplex could interact with
the DxxxML motif in the e37b sequence to mediate their coint-
ernalization from the cell surface. Our data support this concept,
since mutating the DxxxLL motif in CaV2.2e37a to DxxxAL slows
its endocytosis only in the additional presence of the D2R,
whereas mutating Yxx motif in the C terminus of CaV2.2e37a
does not (Fig. 9C,G, Table 2). We have also noted that the N
terminus of CaV2.2 contains another Yxx motif, and this is
adjacent to the region important for G-protein modulation (Page
et al., 1998). Furthermore, upon D2R activation, -arrestin may
be recruited to the activated D2R, where it acts as an adaptor for
AP-2-mediated endocytosis (Goodman et al., 1996; Laporte et al.,
2000, 2002; Lan et al., 2009). Here we provide new evidence that
disrupting the recruitment of functional AP-2 by overexpressing
the dominant-negative mutant AP-22 and mutations in
[DE]xxxL[LI] and Yxxmotifs inhibit CaV2.2 endocytosis upon
D2R activation, demonstrating that AP-2 is required for CaV2.2
endocytosis mediated by D2R activation.
In summary, our data demonstrate novel evidence that
CaV2.2 trafficking in cell bodies and neurites is fine-tuned by
alternative splicing of exon 37, and is mediated differentially by
AP-1. Furthermore, alternative splicing of exon 37 also modu-
lates the effect on trafficking of CaV2.2 resulting from D2R inter-
action and activation. Blocking the interaction of APs with the
binding motif in the proximal C terminus of CaV2.2 may modu-
late calcium entry into neurons and the response to dopamine
receptor activation.
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